China Life Insurance Company related stories
All articles and analysis
Global Investor 150: The 2026 top 10Between them, the 10 largest investors on this year’s Global Investor 150 ranking have $1.1trn allocated to private equity, with an average allocation of 21%.
Side Letter: PIK-ing a winnerWhy payment-in-kind interest is sometimes unfairly maligned. Plus: Partners Group is understood to be on track for a record year of secondaries deployment. Here's today's brief, for our valued subscribers only.
Side Letter: Performance anxietyIf you're reading this from the UK, we hope you enjoyed the long weekend. In today's brief, the Australian government is rethinking an LP performance test that could unlock billions for private markets; and a US foundation is going against the grain. For our valued subscribers only.
Meet the biggest investors in private equity – the Global Investor 150LPs continue to allocate record amounts of capital to the asset class, with Temasek retaining its title as the largest institution on the Global Investor 150 ranking.
Global Investor 150: This year’s top 10This year’s Global Investor 150 top 10 has a collective $976bn allocated to private equity.
Side Letter: Tariff, or not tariff?Tariffs are infusing multiple layers of uncertainty into valuations, which could delay deal activity and prolong holding periods. Plus: OTPP will bid Hong Kong adieu; and Oakley Capital hits its hard-cap. Here's today's brief, for our valued subscribers only.
Side Letter: Pluralsight's PE/PD implicationsThe high-profile Pluralsight restructuring highlights the changing relationship between private equity sponsor and private credit manager. Plus: the Australian regulator appears to be taking a leaf out of the SEC's book. Here's today's brief, for our valued subscribers only.
Global Investor 150: This year's top 10The upper echelon of this year’s GI 150 ranking collectively holds $930bn in private equity assets – 16% more than last year.
Side Letter: QIC's European expansion; PE's healthcare revivalAustralian LP giant QIC just got more firepower in Europe with a mandate from Denmark's PenSam. Plus: private equity's healthcare appetite is making a strong recovery; and findings from iCapital's adviser survey. Here's today's brief, for our valued subscribers only.
Side Letter: Rede's impact whitepaper; Barclays' Moonfare hire; L Catterton's GP stake saleA sneak preview of Rede's latest LP survey. Plus: Barclays Private Bank has tapped Moonfare for its private markets team and L Catterton has parted with a GP stake. Here’s today's brief, for our valued subscribers only.